Phase I/II study on cytarabine and idarubicin combined with escalating doses of clofarabine in newly diagnosed patients with acute myeloid leukaemia and high risk for induction failure (AMLSG 17-10 CIARA trial)

Erstveröffentlichung

2018

Metadata only
Search for full text

Wissenschaftlicher Artikel

Authors

Krauter, Juergen

Fiedler, Walter

Schlenk, Richard Friedrich

Paschka, Peter

Thol, Felicitas

et al.

Institutions

UKU. Klinik für Innere Medizin III

Published in

British Journal of Haematology ; 183 (2018), 2. - S. 235-241. - ISSN 0007-1048. - eISSN 1365-2141

Link to publication

https://dx.doi.org/10.1111/bjh.15546

Funding information

Sanofi Genzyme
DFG [HE 5240/6-1]

Dewey Decimal Group

DDC 610 / Medicine & health

---

Metadata

Show full item record